Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
50%
Ph phase_4
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting2
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (50.0%)
Phase 42 (50.0%)

Trials by Status

completed125%
unknown125%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingphase_3

Trial to Determine Effective Aspirin Dose in COPD

NCT05265299
completedphase_4

Body Weight, Aspirin Dose and Pro-resolving Mediators

NCT04697719
recruitingphase_3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

NCT06408181
unknownphase_4

Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension

NCT04908982

Clinical Trials (4)

Showing 4 of 4 trials
NCT05265299Phase 3

Trial to Determine Effective Aspirin Dose in COPD

Recruiting
NCT04697719Phase 4

Body Weight, Aspirin Dose and Pro-resolving Mediators

Completed
NCT06408181Phase 3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Recruiting
NCT04908982Phase 4

Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4